This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Leidos Holdings (LDOS) Outperforming Other Aerospace Stocks This Year?
by Zacks Equity Research
Is (LDOS) Outperforming Other Aerospace Stocks This Year?
Lockheed Wins $2.4B Deal to Supply Spares for F-35 Jets
by Zacks Equity Research
Lockheed Martin (LMT) secures deal to provide global spares packages, base spares packages, deployment spares packages, afloat spares packages and associated consumables for the F-35 aircraft.
Lockheed Martin Secures Navy Deal to Support CH-53K Aircraft
by Zacks Equity Research
Lockheed Martin (LMT) wins deal to procure spare parts for repairing and maintaining CH-53K aircraft.
LDOS vs. LHX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LDOS vs. LHX: Which Stock Is the Better Value Option?
Lockheed Martin Wins $32M Deal to Modify F-35 Aircraft Program
by Zacks Equity Research
Lockheed Martin (LMT) secures deal to support retrofit of delivered F-35 Lightning II Joint Strike Fighter jets.
Leidos (LDOS) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Leidos (LDOS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Leidos (LDOS) Acquires IMX to Expand Health Business
by Zacks Equity Research
Leidos Holdings' (LDOS) acquisition of IMX Medical Management Services will allow it to expand the health business across the United States.
Zacks.com featured highlights include: AMETEK, Leidos, T. Rowe Price, TransUnion and OneMain
by Zacks Equity Research
Zacks.com featured highlights include: AMETEK, Leidos, T. Rowe Price, TransUnion and OneMain
5 Stocks With Attractive Sales Growth Worth Buying Right Now
by Swayta Shah
Solid sales growth is one of the most important characteristics of potential winners in the stock market.
4 Defense Stocks to Buy as North Korea Ramps Up Weapons Test
by Aparajita Dutta
The latest firing is the fifth short-range missile test by North Korea since Jul 25. U.S. defense contractors have a reason to cheer as the conflict is likely to boost weaponries demand.
Lockheed Martin Wins $107.4M Deal to Support CH-53K Aircraft
by Zacks Equity Research
Lockheed's (LMT) Sikorsky unit will procure long lead items for six CH-53K aircraft from the Lot IV of the jet's low-rate initial production.
Has Leidos Holdings (LDOS) Outpaced Other Aerospace Stocks This Year?
by Zacks Equity Research
Is (LDOS) Outperforming Other Aerospace Stocks This Year?
Northrop Grumman (NOC) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Northrop Grumman (NOC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Defense Stock Roundup: US-North Korea Conflict, Q2 Earnings Beat at LDOS & AJRD
by Zacks Equity Research
Over the past five trading sessions, the defense biggies put up a dismal show, with General Dynamics and Textron losing the most.
Leidos Holdings' (LDOS) Q2 Earnings Beat, 2019 EPS View Up
by Zacks Equity Research
Leidos Holdings (LDOS) reports better-than-expected earnings and revenues in second-quarter 2019. Also, the company partially raises its outlook for the current year.
Leidos (LDOS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Leidos (LDOS) delivered earnings and revenue surprises of 5.45% and 3.44%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Leidos Holdings (LDOS) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Leidos Holdings' (LDOS) second-quarter 2019 earnings are likely to be impacted by poor operating margin performance.
Analysts Estimate Leidos (LDOS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Leidos (LDOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lockheed Martin Wins $175M Deal to Support LRASM Systems
by Zacks Equity Research
Lockheed Martin's (LMT) LRASM is a precision-guided anti-ship missile that integrates an enhanced digital anti-jam GPS to detect and destroy specific targets among a group of ships at sea.
Why Leidos (LDOS) Could Beat Earnings Estimates Again
by Zacks Equity Research
Leidos (LDOS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Leidos (LDOS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Leidos (LDOS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Lockheed Martin Wins $106M Deal to Support Apache Helicopter
by Zacks Equity Research
Lockheed Martin's (LMT) M-TADS/PNVS systems is an electro-optical sensor that provides enhanced situational awareness to Apache Helicopter's aircrew.
L3 Technologies Wins Deal to Upgrade Navy Submarine Sensors
by Zacks Equity Research
L3 Technologies' (LLL) Micreo acquisition played a key role in winning the latest deal pertaining to the submarine photonics mast programs.
Lockheed Martin Secures $562M FMS Deal for ATACMS Missile
by Zacks Equity Research
Lockheed Martin's (LMT) ATACMS is a long-range guided missile that is capable of striking targets well beyond the range of existing Army cannons, rockets and other missiles.
Leidos Holdings to Provide IAAI Solutions and Services to HHS
by Zacks Equity Research
Leidos Holdings (LDOS) will deploy AI solution and assist government agencies to develop business processes as well as enhance mission delivery.